Absorbable vs. non-absorbable antibiotics in the treatment of small intestine bacterial overgrowth in patients with blind-loop syndrome.
about
Small intestinal bacterial overgrowth syndromeUse and abuse of hydrogen breath testsSmall intestinal bacterial overgrowth: diagnosis and treatment.Colonic hypersensitivity is a major determinant of the efficacy of bloating treatment in constipation-predominant irritable bowel syndrome.Diagnosis and management of small intestinal bacterial overgrowth.Small intestinal bacterial overgrowth: a comprehensive reviewDiagnosis and treatment of small intestinal bacterial overgrowth.Recent advances in small bowel diseases: Part I.Diagnosis of small intestinal bacterial overgrowth: the challenges persist!Diagnosis and pharmacological management of small intestinal bacterial overgrowth in children with intestinal failureReview article: small intestinal bacterial overgrowth--prevalence, clinical features, current and developing diagnostic tests, and treatment.Review article: The nutritional and pharmacological consequences of obesity surgery.Systematic review with meta-analysis: rifaximin is effective and safe for the treatment of small intestine bacterial overgrowth.A Case of Blind Loop Syndrome Caused by Infection with Giardia duodenalis Diagnosed with Double Balloon Enteroscopy.Aciduric Strains of Lactobacillus reuteri and Lactobacillus rhamnosus, Isolated from Human Feces, Have Strong Adhesion and Aggregation Properties.Lactulose hydrogen breath test and functional symptoms in pediatric patients.The role of small intestinal bacterial overgrowth in postgastrectomy patients.Therapeutic efficacy of amoxicillin and rifaximin in patients with small intestinal bacterial overgrowth and infection
P2860
Q24262889-91ECBEA0-CF7C-416D-A3BC-ABFA735FAD28Q24680269-A0EEDA97-B762-4C85-8146-98D08A8051CEQ33438120-D4B5B45F-A530-47A8-AF92-6CEB7DEAD468Q33448962-58ADE1A2-8CF8-4209-9F85-A553F52B1685Q33457767-C4EF7052-9C07-4D2A-9A20-62E14560D2ACQ34996846-8CBC2A0E-06D2-4988-9DB9-FDDC10B0F490Q35860893-30D30B8A-1F6C-4D5C-9ADF-1F0F58CE08E1Q36093331-BBE35012-0F36-49A9-926B-83B0BFDD7F88Q37390656-0256719A-C26F-49AD-B065-953450884705Q37831805-35CD1999-400C-4B53-844A-02CACA860862Q38129946-B72FB421-AABD-48F1-941F-010F01795A7CQ38235543-FD28AAFD-BF5B-49D3-B389-D81CB9C9C3A5Q39081757-0B294A91-C796-4ADD-B525-EEE7BBC7525DQ41656440-04AFA9B0-721A-4860-B510-0AE66F36DD9AQ46971057-85B045E6-CD90-4E31-97DA-47882E60E2E2Q51432735-E79E1618-09CF-4B3A-82FF-68BA4504EF1DQ53438153-AA7A9C54-043F-4EDE-B65A-C839F7B3642AQ57301725-B7AA747C-C352-405D-BAA1-3946BABA3302
P2860
Absorbable vs. non-absorbable antibiotics in the treatment of small intestine bacterial overgrowth in patients with blind-loop syndrome.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年学术文章
@wuu
2005年学术文章
@zh
2005年学术文章
@zh-cn
2005年学术文章
@zh-hans
2005年学术文章
@zh-my
2005年学术文章
@zh-sg
2005年學術文章
@yue
2005年學術文章
@zh-hant
name
Absorbable vs. non-absorbable ...... ents with blind-loop syndrome.
@en
Absorbable vs. non-absorbable ...... ents with blind-loop syndrome.
@nl
type
label
Absorbable vs. non-absorbable ...... ents with blind-loop syndrome.
@en
Absorbable vs. non-absorbable ...... ents with blind-loop syndrome.
@nl
prefLabel
Absorbable vs. non-absorbable ...... ents with blind-loop syndrome.
@en
Absorbable vs. non-absorbable ...... ents with blind-loop syndrome.
@nl
P2093
P2860
P1476
Absorbable vs. non-absorbable ...... ients with blind-loop syndrome
@en
P2093
A Missanelli
M Di Stefano
S Mazzocchi
P2860
P304
P356
10.1111/J.1365-2036.2005.02397.X
P407
P577
2005-04-01T00:00:00Z